- [(18)F]Fluorodeoxyglucose Positron Emission Tomography for Detection of Bone Marrow Involvement in Children and Adolescents With Hodgkin's Lymphoma
[作者:Purz, S; Mauz-Korholz, C; Korholz, D; Hasenclever, D; Krausse, A; Sorge, I; Ruschke, K; Stiefel, M; Amthauer, H; Schober, O; Kranert, WT; Weber, WA; Haberkorn, U; Hundsdorfer, P; Ehlert, K; Becker, M; Rossler, J; Kulozik, AE; Sabri, O; Kluge, R,期刊:Journal of clinical oncology, 页码:3523-3528 , 文章类型: Article,,卷期:2011年29-26]
- Purpose Currently, a routine bone marrow biopsy (BMB) is performed to detect bone marrow (BM) involvement in pediatric Hodgkin's lymphoma (HL) stage greater than IIA. [(18)F] fluorodeoxyglucose positron emission tomograp...
- A Randomized, Phase II, Biomarker-Selected Study Comparing Erlotinib to Erlotinib Intercalated With Chemotherapy in First-Line Therapy for Advanced Non-Small-Cell Lung Cancer
[作者:Hirsch, FR; Kabbinavar, F; Eisen, T; Martins, R; Schnell, FM; Dziadziuszko, R; Richardson, K; Richardson, F; Wacker, B; Sternberg, DW; Rusk, J; Franklin, WA; Varella-Garcia, M; Bunn, PA; Camidge, DR,期刊:Journal of clinical oncology, 页码:3567-3573 , 文章类型: Article,,卷期:2011年29-26]
- Purpose Erlotinib prolongs survival in patients with advanced non-small-cell lung cancer (NSCLC). We report the results of a randomized, phase II study of erlotinib alone or intercalated with chemotherapy (CT + erlotinib...
- Clinical Features and Outcome of Patients With Non-Small-Cell Lung Cancer Harboring BRAF Mutations
[作者:Marchetti, A; Felicioni, L; Malatesta, S; Sciarrotta, MG; Guetti, L; Chella, A; Viola, P; Pullara, C; Mucilli, F; Buttitta, F,期刊:Journal of clinical oncology, 页码:3574-3579 , 文章类型: Article,,卷期:2011年29-26]
- Purpose To investigate the prevalence, distribution, and prognostic role of BRAF mutations in a large cohort of white patients with non-small-cell lung cancer (NSCLC). Patients and Methods A retrospective series of 1,046...
- Bendamustine Combined With Rituximab in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group
[作者:Fischer, K; Cramer, P; Busch, R; Stilgenbauer, S; Bahlo, J; Schweighofer, CD; Bottcher, S; Staib, P; Kiehl, M; Eckart, MJ; Kranz, G; Goede, V; Elter, T; Buhler, A; Winkler, D; Kneba, M; Dohner, H; Eichhorst, BF; Hallek, M; Wendtner, CM,期刊:Journal of clinical oncology, 页码:3559-3566 , 文章类型: Article,,卷期:2011年29-26]
- Purpose The objective of this trial was to evaluate safety and efficacy of bendamustine combined with rituximab (BR) in patients with relapsed and/or refractory chronic lymphocytic leukemia (CLL). Patients and Methods Se...
- Cause-Specific Colostomy Rates After Radiotherapy for Anal Cancer: A Danish Multicentre Cohort Study
[作者:Sunesen, KG; Norgaard, M; Lundby, L; Havsteen, H; Buntzen, S; Thorlacius-Ussing, O; Laurberg, S,期刊:Journal of clinical oncology, 页码:3535-3540 , 文章类型: Article,,卷期:2011年29-26]
- Purpose In anal cancer, colostomy-free survival is a measure of anal sphincter preservation after treatment with radiotherapy or chemoradiotherapy. Failure to control anal cancer and complications of treatment are altern...
- Natural Course of Insomnia Comorbid With Cancer: An 18-Month Longitudinal Study
[作者:Savard, J; Ivers, H; Villa, J; Caplette-Gingras, A; Morin, CM,期刊:Journal of clinical oncology, 页码:3580-3586 , 文章类型: Article,,卷期:2011年29-26]
- Purpose This study aimed to assess the prevalence and natural course (incidence, persistence, remission, and relapse) of insomnia comorbid with cancer during an 18-month period. Patients and Methods All patients schedule...
- Phase I Trial of MK-0752 in Children With Refractory CNS Malignancies: A Pediatric Brain Tumor Consortium Study
[作者:Fouladi, M; Stewart, CF; Olson, J; Wagner, LM; Onar-Thomas, A; Kocak, M; Packer, RJ; Goldman, S; Gururangan, S; Gajjar, A; Demuth, T; Kun, LE; Boyett, JM; Gilbertson, RJ,期刊:Journal of clinical oncology, 页码:3529-3534 , 文章类型: Article,,卷期:2011年29-26]
- Purpose To estimate the maximum-tolerated dose (MTD), describe dose-limiting toxicities (DLTs), and characterize pharmacokinetic properties of MK-0752, a gamma secretase inhibitor, in children with refractory or recurren...
- Outcome Analyses After the First Admission to an Intensive Care Unit in Patients With Advanced Cancer Referred to a Phase I Clinical Trials Program
[作者:Fu, SQ; Hong, DS; Naing, A; Wheler, J; Falchook, G; Wen, SJ; Howard, A; Barber, D; Nates, J; Price, K; Kurzrock, R,期刊:Journal of clinical oncology, 页码:3547-3552 , 文章类型: Article,,卷期:2011年29-26]
- Purpose This study assessed outcomes of individuals with advanced cancer who required admission to an intensive care unit (ICU) after referral for an early clinical trial because they did not respond to conventional ther...
- Inflammation and Behavioral Symptoms After Breast Cancer Treatment: Do Fatigue, Depression, and Sleep Disturbance Share a Common Underlying Mechanism?
[作者:Bower, JE; Ganz, PA; Irwin, MR; Kwan, L; Breen, EC; Cole, SW,期刊:Journal of clinical oncology, 页码:3517-3522 , 文章类型: Article,,卷期:2011年29-26]
- Purpose Fatigue, depression, and sleep disturbance are common adverse effects of cancer treatment and frequently co-occur. However, the possibility that inflammatory processes may underlie this constellation of symptoms ...
|